JASPER THERAPEUTICS, INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage
JASPER THERAPEUTICS, INC. (JSPR) had Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage of 60.00% as of 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage · last filed 2021-05-24
- 2020-12-31: Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage 60.00%.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage |
|---|---|
| 2020-12-31 | 60.00% 10-K/A · filed 2021-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |